PCK 0.00% 3.2¢ painchek ltd

Media Thread, page-960

  1. 6,687 Posts.
    lightbulb Created with Sketch. 1669
    While the facial assessment is a key feature of Painchek technology, it is not meant to replace all other forms of assessment. The manual assessments are still necessary for a comprehensive evaluation of pain in non-verbal patients. Painchek technology is designed to augment and assist in the assessment process, not to replace it entirely. Additionally, the clinical trial you mentioned was conducted to compare the accuracy of Painchek with the existing standard, which includes the manual assessments. Overall, the use of Painchek technology can help healthcare professionals make more informed decisions and improve patient outcomes.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $52.39M
Open High Low Value Volume
3.2¢ 3.2¢ 3.2¢ $5.469K 170.9K

Buyers (Bids)

No. Vol. Price($)
2 44930 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 108791 1
View Market Depth
Last trade - 14.22pm 06/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.